New World Medical Secured EU MDR Certification
The company completed a transition to updated European Union regulatory standards for three core glaucoma products.
Updated on Oct. 6, 2026 in Biotech
Live Poll
Do you believe stricter medical device regulations improve the quality of care for patients?
New World Medical has successfully obtained Medical Device Regulation (MDR) certification for the Ahmed Glaucoma Valve, Ahmed ClearPath, and KDB GLIDE. This milestone updates the compliance status of these products, which were previously governed by the older Medical Device Directive framework within the European Union.
Why it matters
This certification ensures the continued availability of these surgical tools within the European Union by meeting updated safety and performance requirements. The transition marks a necessary step for the company to maintain its market footprint as legacy regulatory frameworks phase out.
The certification covers three established glaucoma surgical devices that were previously maintained under the older Medical Device Directive. The company has not yet secured similar MDR certification for its Ahmed ClearPath ST, a device currently approved in over 20 countries.
The players
New World Medical
A Rancho Cucamonga-based medical device manufacturer specializing in ophthalmic surgical products and glaucoma management technologies.
The details
The certification process involved transitioning from the legacy Medical Device Directive (MDD) to the more rigorous European Union Medical Device Regulation (MDR) requirements. The company collaborated with a notified body—an organization designated by an EU country to assess the conformity of medical devices before they are placed on the market—to verify compliance with the updated safety and clinical standards. This shift is part of a broader industry-wide migration to the newer regulatory mandate.
Timeline
October 6, 2026: New World Medical announced the receipt of the EU MDR certification.
The Tech Race
The certification follows the implementation of the European Union Medical Device Regulation, which sets new safety standards for all medical technologies sold in the bloc. This transition marks the firm's adherence to the updated compliance mandate that has forced manufacturers to re-evaluate their entire product portfolios against stricter clinical data requirements.
The certification ensures that the Ahmed Glaucoma Valve, Ahmed ClearPath, and KDB GLIDE remain available for surgeons and patients across the European Union. Future updates to the company's portfolio depend on the successful completion of similar certification processes for remaining products like the Ahmed ClearPath ST.
The takeaway
This certification signals a successful alignment with current European regulatory demands for ophthalmic devices. The next indicator of progress will be the company's eventual MDR certification for the Ahmed ClearPath ST, which remains a key benchmark for their European market strategy.
Further reading
Learn more about the latest regulatory shifts and innovations in Biotech.
More information
For more information on the company's product line and regulatory updates, visit the New World Medical official website.
Live Poll
Do you believe stricter medical device regulations improve the quality of care for patients?
